Michael Schuster
Corporate Officer/Principal chez MESOBLAST LIMITED
Postes actifs de Michael Schuster
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MESOBLAST LIMITED | Corporate Officer/Principal | 01/01/2004 | - |
| Investor Relations Contact | 01/01/2004 | - | |
| Public Communications Contact | 01/01/2004 | - |
Historique de carrière de Michael Schuster
Anciens postes connus de Michael Schuster
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Angioblast Systems, Inc. | Investor Relations Contact | - | - |
Mesoblast, Inc.
 Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Directeur des opérations | 23/04/2009 | - |
| Fondateur | 01/01/2001 | - | |
| Corporate Officer/Principal | 01/01/2001 | 23/04/2009 |
Formation de Michael Schuster
| Fordham University | Masters Business Admin |
| Tufts University | Undergraduate Degree |
| New York Medical College | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Australie | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Investor Relations Contact | 2 |
| Chief Operating Officer | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MESOBLAST LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
Mesoblast, Inc.
Mesoblast, Inc. Pharmaceuticals: MajorHealth Technology Mesoblast, Inc. manufactures and distributes biopharmaceutical products. It develops cellular medicines for under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions. The company was founded by Michael Schuster and Silviu Itescu in 2004 and is headquartered in New York, NY. | Health Technology |
| Angioblast Systems, Inc. |
- Bourse
- Insiders
- Michael Schuster
- Expérience
